Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Issue of Shares

6th Nov 2009 12:19

RNS Number : 1252C
Ipso Ventures PLC
06 November 2009
 



Issue of New Shares

The Company announces the subscription by R&B Trust Corporation Limited, the trustee of the IPSO Employee Benefit Trust (the "Trust"), for 450,590 ordinary shares of 5p each ("Ordinary Shares") in the Company at a price of 50p per share.

These shares will be used by the Trust to satisfy the grants of options to eligible employees. 

Application has now been made for the Ordinary Shares to be admitted to trading on AIM, which is expected to occur at 8.00am on 12th November 2009.

Following Admission, the Company will have 13,177,445 Ordinary shares in issue.

For further information, please contact:

IPSO Ventures plc

Simon Hunt, Executive Chairman

Nick Rodgers, Chief Executive Officer

Tel: 020 7921 2990 

[email protected]

[email protected]

www.ipsoventures.com

Ambrian Partners Limited

Samantha Harrison

Tel: 020 7634 4712

[email protected]

Old Park Lane Capital plc

Michael Parnes

Tel: 020 7493 8188 

[email protected]

Rawlings Financial PR Limited

Catriona Valentine

Tel: 01653 618 016

[email protected]

www.rawlingsfinancial.co.uk

  Company description:

IPSO creates commercial value from technology and its business model is entirely demand driven. It works closely with its industrial collaborators to identify the demand for new, innovative technologies and then, through its strong relationships with research institutions, sources technologies which could meet those needs. Much of this technology requires considerable further work by IPSO before it can be sold to industry as a developed product. IPSO creates businesses and provides expertise, strategic direction, human and seed capital, as well as corporate finance advice.

For industrial collaborators, IPSO provides a mechanism to identify and develop technologies which could be of significant value to their businesses, and removes the risk to them of acquiring raw, unproven and undeveloped technology.

For research institutions, IPSO provides greater certainty that their technology will find commercial success.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOECKAKDBBDDODK

Related Shares:

PPG.L
FTSE 100 Latest
Value8,275.66
Change0.00